EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Decision regret following rapid genetic testing at the time of breast cancer diagnosis

Ling-Fang Hsu, Andrea Eisen, Aletta Poll, David W Lim iD, Frances C Wright, Renee Hanrahan, Alana Hosein, Tuya Pal, Steven Narod iD, Kelly Metcalfe iD

Cancer · 01.11.2026 · 132 (21)

DOI: 10.1002/cncr.70663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 01.11.2026. Verfasst von Ling-Fang Hsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Testing, Decision Making, Emotions. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Women's College Hospital Foundation, Peter Gilgan Centre for Women's Cancer, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Genetic testing is increasingly being offered at the time of breast cancer diagnosis to help women guide their treatment decisions. The objective of the current study was to measure decision regret 1 year after genetic testing and to evaluate the factors associated with regret.

Methods

Women from across Canada were referred to receive rapid genetic testing for breast cancer predisposition genes at the time of breast cancer diagnosis ( BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, TP53, ATM, and CHEK2) . Questionnaires were completed prior to testing and 1‐week and 1‐year postgenetic testing. Decision regret was measured at one‐year.

Results

Overall, 871 women participated and the mean age at diagnosis was 46.0 years (range 19–70 years), and 522 (59.9%) of the women were White. Pathogenic variants were found in 83 women (9.5%). The mean score for decision regret was 7.86 (SD 14.17), with 802 women (92.1%) having no regret and 69 participants (7.9%) having regret. Women from racialized groups were more likely to regret their decision compared to White women (13.4% vs 4.4%; p < .001). Those with a BRCA1 or BRCA2 pathogenic variant were significantly more likely to have regret compared to those with a negative result ( p = .03).

Conclusion

A minority of women who have rapid genetic testing at the time of breast cancer diagnosis later regret their decision. Women at greater risk of having decision regret included those who received a positive BRCA1 or BRCA2 genetic test, and those from racialized groups. Follow‐up counseling may be warranted for those who experience decision regret.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGenetic TestingDecision MakingEmotionsHumansFemaleMiddle AgedAdultAgedGenetic Predisposition to DiseaseCanadaYoung AdultSurveys and QuestionnairesBRCA2 ProteinBRCA1 ProteinGenetic Counseling

Stichwörter der Autor:innen

breast cancerdecision regretgenetic counsellinggenetic testingrapid genetic testing

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.
  • Women's College Research and Innovation Institute, Toronto, Ontario, Canada.
  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Royal Victoria Regional Health Centre, Barrie, Ontario, Canada.
  • Trillium Health Centre, Mississauga, Ontario, Canada.

ORCID-Profile: David W Lim, Steven Narod, Kelly Metcalfe

Förderung

  • Women's College Hospital Foundation
  • Peter Gilgan Centre for Women's Cancer
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Hsu, L. F., Eisen, A., Poll, A., Lim, D. W., Wright, F. C., Hanrahan, R., Hosein, A., Pal, T., Narod, S., & Metcalfe, K. (2026). Decision regret following rapid genetic testing at the time of breast cancer diagnosis. Cancer, 132(21). https://doi.org/10.1002/cncr.70663

Vancouver

Hsu LF, Eisen A, Poll A, Lim DW, Wright FC, Hanrahan R, et al. Decision regret following rapid genetic testing at the time of breast cancer diagnosis. Cancer. 2026;132(21). doi:10.1002/cncr.70663

BibTeX
@article{Hsu2026,
  author = {Hsu, Ling-Fang and Eisen, Andrea and Poll, Aletta and Lim, David W and Wright, Frances C and Hanrahan, Renee and Hosein, Alana and Pal, Tuya and Narod, Steven and Metcalfe, Kelly},
  title = {Decision regret following rapid genetic testing at the time of breast cancer diagnosis},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {21},
  doi = {10.1002/cncr.70663}
}
Kostenlos starten →